$99.99 Original price was: $99.99.$63.00Current price is: $63.00.
Nicotinic acetylcholine receptors (nAChRs) play a crucial role in various diseases such as Alzheimer’s, Parkinson’s, and schizophrenia, making them a potential therapeutic target for treatment. This book provides an in-depth analysis of the roles and functions of nAChRs within and outside the nervous system, with a focus on their translational implications and future prospects for treating numerous disorders.
Nicotinic receptors are expressed throughout the nervous system and are involved in various physiological processes. They are key players in the regulation of cognitive functions, motor control, and reward processing. The book delves into the specific roles of nAChRs in different regions of the brain and their involvement in various neurological disorders.
Alzheimer’s disease is a neurodegenerative disorder characterized by cognitive decline and memory loss. nAChRs have been implicated in the pathogenesis of Alzheimer’s, with studies suggesting that they play a role in the regulation of amyloid-β, a key component of the amyloid plaques characteristic of the disease. The book discusses the potential therapeutic strategies targeting nAChRs for the treatment of Alzheimer’s.
Parkinson’s disease is a motor disorder characterized by tremors, rigidity, and bradykinesia. nAChRs are expressed in the dopamine-producing neurons of the substantia nigra, which are affected in Parkinson’s disease. The book explores the potential of nAChR modulation as a therapeutic approach for Parkinson’s, highlighting the potential benefits and challenges of this strategy.
While primarily associated with neurological disorders, nAChRs have also been implicated in cancer. The book discusses the role of nAChRs in cancer development and progression, highlighting their potential as therapeutic targets for cancer treatment.
Schizophrenia is a psychiatric disorder characterized by hallucinations, delusions, and disorganized thinking. nAChRs have been implicated in the pathogenesis of schizophrenia, with studies suggesting that they play a role in the regulation of dopamine release and the development of psychotic symptoms. The book reviews the current understanding of nAChRs in schizophrenia and discusses potential therapeutic strategies targeting these receptors.
The book concludes by discussing the future prospects for nAChR modulation as a therapeutic strategy for various diseases. It highlights the challenges and opportunities associated with targeting nAChRs and outlines the potential directions for future research in this field.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline